Freenome Inc (FRNM)

Currency in USD
11.61
+0.06(+0.52%)
Closed·
11.80+0.19(+1.64%)
·
Advertisement
FRNM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.4011.89
52 wk Range
9.9514.47
Key Statistics
Prev. Close
11.61
Open
11.73
Day's Range
11.4-11.89
52 wk Range
9.95-14.47
Volume
611.51K
Average Volume (3m)
355.43K
1-Year Change
9.8392%
Book Value / Share
-148.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FRNM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Operates with a moderate level of debt

Freenome Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral

Earnings

Latest Release
15/07/2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare FRNM to Peers and Sector

Metrics to compare
FRNM
Peers
Sector
Relationship
P/E Ratio
−5.8x−0.8x−0.4x
PEG Ratio
-0.010.00
Price/Book
−1.0x1.6x2.6x
Price / LTM Sales
38.3x2.6x3.1x
Upside (Analyst Target)
-11.6%48.4%
Fair Value Upside
Unlock20.1%6.5%Unlock

Freenome, Inc. operates as a biotechnology company focused on developing blood-based tests for early cancer detection using artificial intelligence and multiomics technology. The company develops and provides blood-based tests for early cancer detection, including a test for colorectal cancer screening. It offers a multiomics platform that combines computational biology, machine learning, and multiple data types to identify biomarkers and detect various cancers. The company conducts clinical research programs, such as the PREEMPT CRC, Sanderson, and Vallania studies, to validate and expand its cancer detection tests to multiple cancer types. It collaborates with healthcare organizations and partners to advance clinical studies and enhance its product portfolio, including an autoantibody platform with additional biomarkers, and provides patient stratification and monitoring solutions using its multiomics technology. The company was founded in 2014 and is based in Brisbane, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
559.17K0.50%6.46M
Other Institutional Investors
65.73M58.24%759.14M
Public Companies & Retail Investors
46.57M41.27%537.91M
Total
112.86M100.00%1.3B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
RA Capital Management, L.P.13.62%15,367,270177,492
RA Capital Healthcare Fund, L.P.10.84%12,230,122141,258

FAQ

What Is the Freenome (NASDAQ: FRNM) Share Price Today?

The Freenome stock price today is 11.61 USD.

What Stock Exchange Does Freenome (FRNM) Trade On?

Freenome is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Freenome?

The stock symbol (also called a 'ticker') for Freenome is "FRNM."

What Is the Current Freenome Market Capitalisation?

As of today, Freenome (NASDAQ: FRNM) market cap is 1.31B USD.

What Is Freenome's (FRNM) Earnings Per Share (TTM)?

The Freenome EPS is currently -8.47 (Trailing Twelve Months).

Is FRNM a Buy or Sell From a Technical Analyst Perspective?

Based on today's Freenome moving averages and other technical indicators, the daily buy/sell signal for FRNM stock is Strong Buy.

How Many Times Has Freenome Stock Split?

Freenome has split 0 times. (See the FRNM stock split history page for full effective split date and price information.)

How Many Employees Does Freenome Have?

Freenome has 363 employees, based on their latest Companies House report.

What is the current trading status of Freenome (NASDAQ: FRNM)?

As of 14/08/2026, Freenome (FRNM) is trading at a share price of 11.61 USD, with a previous close of 11.61 USD. The stock has fluctuated within a day range of 11.40 USD to 11.89 USD, while its 52-week range spans from 9.95 USD to 14.47 USD.

What Is the FRNM Premarket Price?

FRNM's last pre-market stock price is 11.80 USD. The pre-market share volume is 140.00, and the stock has decreased by 0.19, or 1.64%.

What Is the FRNM After Hours Price?

FRNM's last after hours stock price is 11.62 USD, the stock has decreased by 0.01, or 0.09%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.